Serum lactate testing sales will expand through 2036, with table top analyzers at 48% of product sales in 2026. The market was valued at USD 229.8 million in 2025, is projected to reach USD 552.5 million by 2036 and is forecast to record an 8.3% CAGR between 2026 and 2036.